| Product Code: ETC7644963 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Israel continued to rely on antiviral imports from top exporting countries including Switzerland, UK, Belgium, USA, and Germany. The market remained competitive with a low Herfindahl-Hirschman Index (HHI) concentration, indicating a diverse range of suppliers. Despite a slight decline in the Compound Annual Growth Rate (CAGR) from 2020 to 2024 at -2.14%, the market saw a marginal improvement in the growth rate from 2023 to 2024 at -0.41%. Israel`s import landscape for antivirals reflects a balanced mix of sources, contributing to a stable market outlook.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Antivirals Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Antivirals Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Antivirals Market - Industry Life Cycle |
3.4 Israel Antivirals Market - Porter's Five Forces |
3.5 Israel Antivirals Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Israel Antivirals Market Revenues & Volume Share, By Actions, 2021 & 2031F |
4 Israel Antivirals Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of viral infections in Israel |
4.2.2 Technological advancements in antiviral drugs |
4.2.3 Growing awareness about the importance of antiviral treatments |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval in Israel |
4.3.2 High cost of antiviral medications |
4.3.3 Limited access to healthcare services in certain regions of Israel |
5 Israel Antivirals Market Trends |
6 Israel Antivirals Market, By Types |
6.1 Israel Antivirals Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Antivirals Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Israel Antivirals Market Revenues & Volume, By Hepatitis-C antivirals, 2021- 2031F |
6.1.4 Israel Antivirals Market Revenues & Volume, By HIV antivirals, 2021- 2031F |
6.1.5 Israel Antivirals Market Revenues & Volume, By Herpes antivirals, 2021- 2031F |
6.1.6 Israel Antivirals Market Revenues & Volume, By Hepatitis-B antivirals, 2021- 2031F |
6.1.7 Israel Antivirals Market Revenues & Volume, By Influenza antivirals, 2021- 2031F |
6.1.8 Israel Antivirals Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Israel Antivirals Market, By Actions |
6.2.1 Overview and Analysis |
6.2.2 Israel Antivirals Market Revenues & Volume, By DNA polymerase inhibitors, 2021- 2031F |
6.2.3 Israel Antivirals Market Revenues & Volume, By NS3 Protease inhibitors, 2021- 2031F |
6.2.4 Israel Antivirals Market Revenues & Volume, By Reverse transcriptase inhibitors, 2021- 2031F |
6.2.5 Israel Antivirals Market Revenues & Volume, By Others, 2021- 2031F |
7 Israel Antivirals Market Import-Export Trade Statistics |
7.1 Israel Antivirals Market Export to Major Countries |
7.2 Israel Antivirals Market Imports from Major Countries |
8 Israel Antivirals Market Key Performance Indicators |
8.1 Research and development investment in new antiviral drug formulations |
8.2 Number of clinical trials conducted for antiviral drugs in Israel |
8.3 Adoption rate of antiviral treatments among healthcare providers in Israel |
9 Israel Antivirals Market - Opportunity Assessment |
9.1 Israel Antivirals Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Israel Antivirals Market Opportunity Assessment, By Actions, 2021 & 2031F |
10 Israel Antivirals Market - Competitive Landscape |
10.1 Israel Antivirals Market Revenue Share, By Companies, 2024 |
10.2 Israel Antivirals Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here